Literature DB >> 26048179

Fear extinction, persistent disruptive behavior and psychopathic traits: fMRI in late adolescence.

Moran D Cohn1, Koen van Lith2, Merel Kindt3, Louise E Pape4, Theo A H Doreleijers2, Wim van den Brink5, Dick J Veltman6, Arne Popma7.   

Abstract

Children diagnosed with a Disruptive Behavior Disorder (DBD, i.e. Oppositional Defiant Disorder or Conduct Disorder), especially those with psychopathic traits, are at risk of developing persistent and severe antisocial behavior. Reduced fear conditioning has been proposed to underlie persistent antisocial development. However, we have recently shown that both DBD persisters and desisters are characterized by increased fear conditioning compared with healthy controls (HCs). In this study, we investigated whether brain function during fear extinction is associated with DBD subgroup-membership and psychopathic traits. Adolescents from a childhood arrestee cohort (mean age 17.6 years, s.d. 1.4) who met criteria for a DBD diagnosis during previous assessments were re-assessed and categorized as persistent DBD (n = 25) or desistent DBD (n = 25). Functional MRI during the extinction phase of a classical fear-conditioning task was used to compare regional brain function between these subgroups and 25 matched controls. Both DBD persisters and desisters showed hyperreactivity during fear extinction, when compared with HCs. Impulsive-irresponsible psychopathic traits were positively associated with responses in the fear neurocircuitry and mediated the association between neural activation and group membership. These results suggest that fear acquisition and fear extinction deficits may provide an endophenotype for an emotionally hyperreactive subtype of antisocial development.
© The Author (2015). Published by Oxford University Press. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  antisocial behavior; extinction; fMRI; fear conditioning; psychopathy

Mesh:

Year:  2015        PMID: 26048179      PMCID: PMC4927023          DOI: 10.1093/scan/nsv067

Source DB:  PubMed          Journal:  Soc Cogn Affect Neurosci        ISSN: 1749-5016            Impact factor:   3.436


  32 in total

1.  Impaired reversal but intact acquisition: probabilistic response reversal deficits in adult individuals with psychopathy.

Authors:  Salima Budhani; Rebecca A Richell; R James R Blair
Journal:  J Abnorm Psychol       Date:  2006-08

2.  Persistent violent offending: what do we know?

Authors:  Sheilagh Hodgins
Journal:  Br J Psychiatry Suppl       Date:  2007-05

Review 3.  Can callous-unemotional traits enhance the understanding, diagnosis, and treatment of serious conduct problems in children and adolescents? A comprehensive review.

Authors:  Paul J Frick; James V Ray; Laura C Thornton; Rachel E Kahn
Journal:  Psychol Bull       Date:  2013-06-24       Impact factor: 17.737

4.  A meta-analysis of instructed fear studies: implications for conscious appraisal of threat.

Authors:  Marie-Luise Mechias; Amit Etkin; Raffael Kalisch
Journal:  Neuroimage       Date:  2009-09-26       Impact factor: 6.556

5.  Neural substrates of individual differences in human fear learning: evidence from concurrent fMRI, fear-potentiated startle, and US-expectancy data.

Authors:  Sonja van Well; Renée M Visser; H Steven Scholte; Merel Kindt
Journal:  Cogn Affect Behav Neurosci       Date:  2012-09       Impact factor: 3.282

6.  Fear conditioning and affective modulation of the startle reflex in male adolescents with early-onset or adolescence-onset conduct disorder and healthy control subjects.

Authors:  Graeme Fairchild; Stephanie H Van Goozen; Sarah J Stollery; Ian M Goodyer
Journal:  Biol Psychiatry       Date:  2007-08-31       Impact factor: 13.382

7.  Abnormal ventromedial prefrontal cortex function in children with psychopathic traits during reversal learning.

Authors:  Elizabeth C Finger; Abigail A Marsh; Derek G Mitchell; Marguerite E Reid; Courtney Sims; Salima Budhani; David S Kosson; Gang Chen; Kenneth E Towbin; Ellen Leibenluft; Daniel S Pine; James R Blair
Journal:  Arch Gen Psychiatry       Date:  2008-05

8.  Risky decisions and response reversal: is there evidence of orbitofrontal cortex dysfunction in psychopathic individuals?

Authors:  D G V Mitchell; E Colledge; A Leonard; R J R Blair
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

9.  Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans.

Authors:  Ralf Veit; Herta Flor; Michael Erb; Christiane Hermann; Martin Lotze; Wolfgang Grodd; Niels Birbaumer
Journal:  Neurosci Lett       Date:  2002-08-16       Impact factor: 3.046

10.  Fear inhibition in high trait anxiety.

Authors:  Merel Kindt; Marieke Soeter
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240

View more
  4 in total

1.  Looming Threats and Animacy: Reduced Responsiveness in Youth with Disrupted Behavior Disorders.

Authors:  Stuart F White; Laura C Thornton; Joseph Leshin; Roberta Clanton; Stephen Sinclair; Dionne Coker-Appiah; Harma Meffert; Soonjo Hwang; James R Blair
Journal:  J Abnorm Child Psychol       Date:  2018-05

2.  REVERSE phenotyping-Can the phenotype following constitutive Tph2 gene inactivation in mice be transferred to children and adolescents with and without adhd?

Authors:  Atae Akhrif; Arunima Roy; Katharina Peters; Klaus-Peter Lesch; Marcel Romanos; Angelika Schmitt-Böhrer; Susanne Neufang
Journal:  Brain Behav       Date:  2021-02-01       Impact factor: 2.708

3.  Extinction of Conditioned Fear in Adolescents and Adults: A Human fMRI Study.

Authors:  Despina E Ganella; Katherine D Drummond; Eleni P Ganella; Sarah Whittle; Jee Hyun Kim
Journal:  Front Hum Neurosci       Date:  2018-01-08       Impact factor: 3.169

4.  Boys with conduct problems and callous-unemotional traits: Neural response to reward and punishment and associations with treatment response.

Authors:  Amy L Byrd; Samuel W Hawes; Jeffrey D Burke; Rolf Loeber; Dustin A Pardini
Journal:  Dev Cogn Neurosci       Date:  2017-12-15       Impact factor: 6.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.